Evidence map›Paper›PMID 40626784›Full record

ArticleAnalytical chemistry2025

Collisional Cross-Section Prediction for Multiconformational Peptide Ions with IM2Deep.

Robbe Devreese, Alireza Nameni, Arthur Declercq, Emmy Terryn, Ralf Gabriels, Francis Impens, Kris Gevaert, Lennart Martens, Robbin Bouwmeester

Abstract read
In one paragraph

Article in Analytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Carafe2 enables high qualitybioRxiv : the preprint server for biology · 2026
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Robbe DevreeseVIB Center for Medical Biotechnology, VIB, Ghent 9052, Belgium.ORCID 0000-0002-3432-1502
Alireza NameniVIB Center for Medical Biotechnology, VIB, Ghent 9052, Belgium.
Arthur DeclercqVIB Center for Medical Biotechnology, VIB, Ghent 9052, Belgium.ORCID 0000-0002-9376-1399
Emmy TerrynVIB Center for Medical Biotechnology, VIB, Ghent 9052, Belgium.
Ralf GabrielsVIB Center for Medical Biotechnology, VIB, Ghent 9052, Belgium.ORCID 0000-0002-1679-1711
Francis ImpensVIB Center for Medical Biotechnology, VIB, Ghent 9052, Belgium.ORCID 0000-0003-2886-9616
Kris GevaertVIB Center for Medical Biotechnology, VIB, Ghent 9052, Belgium.ORCID 0000-0002-4237-0283
Lennart MartensVIB Center for Medical Biotechnology, VIB, Ghent 9052, Belgium.ORCID 0000-0003-4277-658X
Robbin BouwmeesterVIB Center for Medical Biotechnology, VIB, Ghent 9052, Belgium.ORCID 0000-0001-6807-7029

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peptide collisional cross-section (CCS) prediction is complicated by the tendency of peptide ions to exhibit multiple conformations in the gas phase. This adds further complexity to downstream analysis of proteomics data, for example for identification or quantification through feature finding. Here, we present an improved version of IM2Deep that is trained on a carefully curated data set to predict CCS values of multiconformational peptides. The training data is derived from a large and comprehensive set of publicly available data sets. This comprehensive training data set together with a tailored architecture allows for the accurate CCS prediction of multiple peptide conformational states. Furthermore, the enhanced IM2Deep model also retains high precision for peptides with a single observed conformation. IM2Deep is publicly available under a permissive open-source license at https://github.com/compomics/IM2Deep.

Indexed as

PeptidesSoftwareIonsProtein ConformationProteomicsIonsPeptides

Identifiers

PMID40626784
PMCPMC12291050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.